Rod Bristow
CEO @ Breakthrough Victoria
Sydney, Australia
Rod Bristow is a pre-seed investor at Breakthrough Victoria in Sydney focused on Health Care and Medical. Rod Bristow is based out of Melbourne, Victoria and is the CEO of Breakthrough Victoria. Rod previously worked at Investible as a CEO. Rod Bristow attended the Australian National University.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 73%
Last updated:
For AI agents: llms.txt
Industries Rod Bristow invests in
Stages Rod Bristow invests in
Countries Rod Bristow invests in
Investment Focus
Industry
- Health Care 4 (36%)
- Medical 2 (18%)
- Software 2 (18%)
- Medical Device 2 (18%)
- Artificial Intelligence 2 (18%)
Stage
- Pre-Seed 6 (55%)
- Seed 3 (27%)
- Series A 1 (9%)
- Venture - Series Unknown 1 (9%)
Country
- Australia 8 (73%)
- Philippines 1 (9%)
- United States 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Navi Medical Technologies
|
Navi Medical Technologies is a medical device development company. | $4.7M / Venture - Series Unknown / Jul 29, 2026 | |
Mental Jam
|
We are a games studio dedicated to creating impactful experiences that explore mental health. | $97.6K / Pre-Seed / Oct 15, 2025 | |
|
DeepDerm
|
DeepDerm is developing AI-enabled cameras that detect skin cancer without the need for painful biopsies. | $97.6K / Seed / Oct 15, 2025 | |
InnovaIVF
|
InnovaIVF transforms the reproductive technology landscape with innovative solutions. | $97.6K / Pre-Seed / Oct 15, 2025 | |
Harvest B
|
Plant-based meat startup that develops plant-based ingredients for plant-based meat producers by leveraging a smart ingredient system | $2M / Seed / Sep 12, 2025 | |
Remagine Labs
|
Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world. | Pre-Seed / Aug 01, 2025 | |
Fyton Bio
|
FytonBio is a privately held, preclinical-stage biopharmaceutical company specializing in biotechnology research. Their core mission is to achieve functional cures for autoimmune and inflammatory diseases by deleting pathogenic immune cells. The company focuses on developing monoclonal antibodies capable of highly specific depletion of such cellsto durably alter disease progression. | Pre-Seed / Aug 01, 2025 | |
Myostellar
|
Myostellar is creating a first-in-class, highly differentiated biologic therapy that stimulates muscle stem cells to promote muscle regeneration with no fibrosis. | Pre-Seed / Aug 01, 2025 | |
EntroMat
|
EntroMat is a pioneering deep-tech startup transforming the metal powder industry through the advancement of high entropy material (HEM) powders. | $1M / Seed / Mar 27, 2025 | |
JigSpace
|
JigSpace develops an AI-powered 3D visualization and augmented reality platform that enables businesses to create and share interactive “Jigs” for explaining complex products and processes. The company provides tools for spatial presentations, product demonstrations, training, and sales enablement, helping organizations improve understanding,engagement, and communication. | $3.5M / Series A / Apr 06, 2023 | |
| See all 11 investments → | |||
Co-Investors
Alberts Impact Ventures
1 deal together
Investible
1 deal together
KP Rx
1 deal together
Mandalay Venture Partners
1 deal together
Pacific Channel
1 deal together
About Breakthrough Victoria
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Breakthrough Victoria Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Lauren Morrey
Executive Director Development
|
|||
|
Rod Bristow
CEO
|
|||
Josh Funder
Director
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Rod Bristow invest in?
Rod Bristow invests primarily in Health Care, Medical and Software startups, most often at Pre-Seed and Seed stage. Most of the 11 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Rod Bristow last invest?
The most recent investment recorded for Rod Bristow closed in Jul 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
